Home Page Headlines

Perci Health has received an investment from Macmillan Cancer Support to help more people with cancer get the personalised care they need.  Perci Health would not divulge the size of the investment,...

Voting for the UK Health & Protection Awards 2025 is now open. Advisers, brokers and other intermediaries including employee benefit consultants can vote to recognise the providers they believe have been outstanding...

Health insurer Ison Secure has announced the appointment of Camil Younes to the position of vice president of broker partnerships, based in Dubai in the United Arab Emirates.  Younes was previously director...

Ocushield has announced that former Axa Health CEO Keith Gibbs has joined the eye screening service as an adviser.  Gibbs (pictured right) was CEO of Axa Health for 17 years from 2001...

Everyone would take out protection if they could hear calls with customers. This is according to independent consultant, Phil Deacon (pictured right), who took part in a panel session at Health &...

Yannis Mamalis, CEO and founder of International Brokers, based in Greece speaks to Health & Protection on how he built a career in international health and benefits, how his degree in physics helped...

The upward trend in the growth of the income protection market is largely because of increased levels of awareness among both advisers and consumers, according to Rose St Louis, protection director of...

Towergate Employee Benefits has hired Charlie Goodman as client director at Towergate Employee Benefits. Goodman has 20 years' experience in financial services including stints at Matioli Woods, Brooks Macdonald, Broadstone, Grant Thornton...

Genetic testing can go a long way in predicting certain diseases or conditions, but that has to be balanced with the danger of people being unfairly denied protection insurance, Health & Protection’s...

LV= has joined CIExpert’s life and critical illness (CI) cover and income protection IP) Insight Zones. It means subscribers can see key elements of all LV’s life, CI and IP propositions, including...